Laboratory Corp of America Holdings logo

Laboratory Corp of America Holdings

FRA:LAB (USA)   Ordinary Shares
€ 195.00 (+0.52%) May 15
43.07
P/B:
2.26
Market Cap:
€ 16.62B ($ 18.06B)
Enterprise V:
€ 22.05B ($ 23.96B)
Volume:
-
Avg Vol (2M):
39.00
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Laboratory Corp of America Holdings ( FRA:LAB ) from 1991 to May 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Laboratory of America stock (FRA:LAB) PE ratio as of May 16 2024 is 43.07. More Details

Laboratory Corp of America Holdings (FRA:LAB) PE Ratio (TTM) Chart

To

Laboratory Corp of America Holdings (FRA:LAB) PE Ratio (TTM) Historical Data

Total 1265
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Laboratory of America PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-17 42.4 2024-03-11 45.4
2024-05-15 42.4 2024-03-08 45.6
2024-05-14 42.1 2024-03-07 45.6
2024-05-13 41.7 2024-03-06 45.6
2024-05-10 41.5 2024-03-05 45.9
2024-05-09 40.6 2024-03-04 45.9
2024-05-08 40.6 2024-03-01 45.6
2024-05-07 40.4 2024-02-29 45.4
2024-05-06 40.6 2024-02-28 45.6
2024-05-03 40.4 2024-02-27 45.6
2024-05-02 40.8 2024-02-26 46.3
2024-04-30 41.3 2024-02-23 45.9
2024-04-29 40.2 2024-02-22 45.4
2024-04-26 40.2 2024-02-21 45.6
2024-04-25 40.2 2024-02-20 45.9
2024-04-24 42.1 2024-02-19 45.9
2024-04-23 41.3 2024-02-16 47.3
2024-04-22 41.3 2024-02-15 48.6
2024-04-19 40.8 2024-02-14 47.7
2024-04-18 40.6 2024-02-13 48.2
2024-04-17 41.3 2024-02-12 47.3
2024-04-16 41.5 2024-02-09 47.3
2024-04-15 41.9 2024-02-08 47.3
2024-04-12 41.7 2024-02-07 47.3
2024-04-11 41.7 2024-02-06 46.8
2024-04-10 41.9 2024-02-05 46.8
2024-04-09 41.9 2024-02-02 47.3
2024-04-08 42.1 2024-02-01 45.9
2024-04-05 42.4 2024-01-31 47.7
2024-04-04 42.4 2024-01-30 47.7
2024-04-03 42.6 2024-01-29 47.3
2024-04-02 43.5 2024-01-26 47.7
2024-03-28 43.2 2024-01-25 46.8
2024-03-27 45.2 2024-01-24 48.2
2024-03-26 45.2 2024-01-23 47.3
2024-03-25 45.2 2024-01-22 47.3
2024-03-22 44.7 2024-01-19 47.7
2024-03-21 43.8 2024-01-18 46.8
2024-03-20 44.5 2024-01-17 46.3
2024-03-19 44.0 2024-01-16 46.8
2024-03-18 44.0 2024-01-12 46.3
2024-03-15 44.0 2024-01-11 46.8
2024-03-14 45.2 2024-01-10 47.7
2024-03-13 45.4 2024-01-09 47.3
2024-03-12 45.6 2024-01-08 46.8

Laboratory Corp of America Holdings (FRA:LAB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Laboratory Corp of America Holdings logo
Laboratory Corp of America Holdings
NAICS : 621511 SIC : 8071
ISIN : US50540R4092

Share Class Description:

FRA:LAB: Ordinary Shares
Description
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.